We are live on
!
Find out more
TGA
TPG GP A Portfolio holdings
AUM
$5B
1-Year Est. Return
58.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+58.56%
3 Year Est. Return
+100.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.1B
AUM Growth
-$1.01B
(-17%)
Cap. Flow
-$856M
Cap. Flow
% of AUM
-16.81%
Top 10 Holdings %
Top 10 Hldgs %
65.64%
Holding
41
New
3
Increased
9
Reduced
12
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$78.3M |
| 2 |
Charles River Laboratories
CRL
|
+$66M |
| 3 |
Analog Devices
ADI
|
+$61.4M |
| 4 |
Amazon
AMZN
|
+$54.4M |
| 5 |
Vulcan Materials
VMC
|
+$22.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
+$575M |
| 2 |
Lamb Weston
LW
|
+$150M |
| 3 |
Ross Stores
ROST
|
+$105M |
| 4 |
Elevance Health
ELV
|
+$95M |
| 5 |
Vaxcyte
PCVX
|
+$82.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.82% |
| 2 | Technology | 17.57% |
| 3 | Consumer Discretionary | 14.41% |
| 4 | Real Estate | 9.46% |
| 5 | Communication Services | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Lifestance Health
LFST
$4.86B
| $866M | 16.99% |
175,284,635
| – | – |
|
2
Life Time Group Holdings
LTH
$9.66B
| $515M | 10.11% |
43,069,730
| – | – |
|
3
Cushman & Wakefield Ltd
CWK
$3.21B
| $434M | 8.52% |
34,832,955
| – | – |
|
4
Progyny
PGNY
$1.99B
| $288M | 5.66% |
9,250,000
-750,000
| -8% | -$27.1M |
|
5
Fidelity National Information Services
FIS
$21.6B
| $251M | 4.93% |
3,703,605
+140,930
| +4% | +$10M |
|
|
6
Elevance Health
ELV
$88.4B
| $225M | 4.42% |
438,582
-187,183
| -30% | -$95M |
|
|
PGRU
7
DELISTED
PropertyGuru Group Limited
PGRU
| $209M | 4.1% |
48,497,728
| – | – |
|
8
Cheniere Energy
LNG
$60.3B
| $205M | 4.02% |
1,367,065
-107,143
| -7% | -$17.9M |
|
9
Microsoft
MSFT
$3.71T
| $180M | 3.54% |
751,916
+85,371
| +13% | +$20.5M |
|
|
10
Lamb Weston
LW
$6.86B
| $171M | 3.35% |
1,910,678
-1,759,242
| -48% | -$150M |
|
11
Liberty Media Series C
FWONK
$23.9B
| $148M | 2.91% |
2,568,956
+31,110
| +1% | +$1.78M |
|
12
Thomson Reuters
TRI
$45.8B
| $143M | 2.81% |
1,192,110
-690,429
| -37% | -$79.6M |
|
13
Comcast
CMCSA
$94B
| $137M | 2.69% |
3,922,865
+526,400
| +15% | +$17.4M |
|
|
14
Amazon
AMZN
$2.79T
| $130M | 2.55% |
1,547,923
+550,550
| +55% | +$54.4M |
|
15
Johnson Controls International
JCI
$87.8B
| $126M | 2.47% |
1,964,118
| – | – |
|
16
Allogene Therapeutics
ALLO
$681M
| $118M | 2.31% |
18,716,306
| – | – |
|
17
Ferguson
FERG
$44.2B
| $101M | 1.99% |
798,778
+91,078
| +13% | +$10.6M |
|
|
EDR
18
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $99.3M | 1.95% |
4,406,280
+3,674,381
| +502% | +$78.3M |
|
19
Pegasystems
PEGA
$6.14B
| $92.1M | 1.81% |
5,380,880
+134,160
| +3% | +$2.32M |
|
|
20
Ross Stores
ROST
$73.7B
| $86.1M | 1.69% |
742,149
-1,031,182
| -58% | -$105M |
|
21
Uber
UBER
$155B
| $71.8M | 1.41% |
2,902,459
| – | – |
|
|
22
Charles River Laboratories
CRL
$13.8B
| $65.9M | 1.29% |
+302,263
| New | +$66M |
|
|
23
Analog Devices
ADI
$176B
| $64.5M | 1.27% |
+393,123
| New | +$61.4M |
|
|
24
Vaxcyte
PCVX
$9.1B
| $57.1M | 1.12% |
1,190,336
-2,095,168
| -64% | -$82.2M |
|
|
TRTX
25
TPG RE Finance Trust
TRTX
$606M
| $48.1M | 0.94% |
7,086,779
| – | – |
|
Similar funds
CPIG
CA
CIC
SFM
VDI
ONB
AAS
TSC
TPG GP A's Q4 2022 Portfolio in Review
As of Q4 2022, TPG GP A held 41 positions worth $5.1B, down 17% from $6.11B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
TPG GP A withdrew a net $856M in Q4 2022, closing 4 positions and reducing 12 holdings. Its most notable exit was Convey Health Solutions Holdings, Inc., an estimated $575M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 45% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TPG GP A opened a new position in Charles River Laboratories worth $65.9M.
- TPG GP A's largest Q4 2022 buy was Charles River Laboratories: 302,263 shares worth $65.9M.
- TPG GP A added most to Endeavor Group Holdings, Inc. in Q4 2022, an estimated $78.3M increase.
- TPG GP A's biggest Q4 2022 reduction was Lamb Weston, cutting an estimated $150M.
- TPG GP A fully exited Convey Health Solutions Holdings, Inc. in Q4 2022, selling an estimated $575M.
- TPG GP A's ten largest holdings make up 66% of its $5.1B portfolio in Q4 2022.
- TPG GP A opened 3 new positions and closed 4 in Q4 2022.
- TPG GP A's portfolio value fell 17% quarter-over-quarter to $5.1B.
Based on TPG GP A's 13F filing for Q4 2022, filed 14 Feb 2023.